Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis

MA Kelshiker, H Seligman, JP Howard… - European heart …, 2022 - academic.oup.com
Aims This meta-analysis aims to quantify the association of reduced coronary flow with all-
cause mortality and major adverse cardiovascular events (MACE) across a broad range of …

The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients

A Velleca, MA Shullo, K Dhital, E Azeka… - The Journal of Heart …, 2023 - jhltonline.org
Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …

The role of cardiac PET in diagnosis and prognosis of ischemic heart disease: optimal modality across different patient populations

M Nayfeh, AI Ahmed, JM Saad, F Alahdab… - Current Atherosclerosis …, 2023 - Springer
Abstract Purpose of Review Despite single-photon emission computerized tomography
(SPECT) being the most used nuclear imaging technique for diagnosis of coronary artery …

Appropriate use criteria for PET myocardial perfusion imaging

TH Schindler, TM Bateman, DS Berman… - Journal of Nuclear …, 2020 - Soc Nuclear Med
In the last decade, myocardial perfusion imaging (MPI) with PET has emerged to play a
pivotal role in the clinical routine process for the detection of hemodynamically significant …

Atlas for reporting PET myocardial perfusion imaging and myocardial blood flow in clinical practice: an information statement from the American Society of Nuclear …

P Chareonthaitawee, TM Bateman, RS Beanlands… - 2023 - Elsevier
Over the past decade, PET myocardial perfusion imaging (MPI) has experienced significant
growth as a pivotal diagnostic and prognostic clinical tool in the non-invasive evaluation of …

PET myocardial blood flow for post-transplant surveillance and cardiac allograft vasculopathy in heart transplant recipients

A Feher, EJ Miller - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review Cardiac allograft vasculopathy (CAV) is a late-occurring
complication of heart transplantation significantly limiting overall graft survival. In the last few …

Non-invasive imaging in the evaluation of cardiac allograft vasculopathy in heart transplantation: a systematic review

SC Ajluni Jr, H Mously, T Chami, J Hajjari… - Current Problems in …, 2022 - Elsevier
Cardiac allograft vasculopathy (CAV) is the leading cause of long-term graft dysfunction in
patients with heart transplantation and is linked with significant morbidity and mortality …

Negative predictive value and prognostic associations of Rb-82 PET/CT with myocardial blood flow in CAV

BQ Abadie, N Chan, Z Sharalaya, P Bhat, S Harb… - Heart Failure, 2023 - jacc.org
Background Invasive coronary angiography (ICA) is the traditional screening modality for
cardiac allograft vasculopathy (CAV). Positron emission tomography/computed tomography …

Cardiac PET myocardial blood flow quantification assessment of early cardiac allograft vasculopathy

S Chih, A Tavoosi, V Nair, AY Chong, V Džavík… - Cardiovascular …, 2024 - jacc.org
Background Positron emission tomography (PET) has demonstrated utility for diagnostic and
prognostic assessment of cardiac allograft vasculopathy (CAV) but has not been evaluated …

Diagnosis and management of cardiac allograft vasculopathy

JM Ortega-Legaspi, PE Bravo - Heart, 2022 - heart.bmj.com
One of the main causes of death beyond the first year after heart transplantation is cardiac
allograft vasculopathy (CAV). This review summarises the current understanding of its …